Identification of novel genes regulating metalloproteinase activity
调控金属蛋白酶活性的新基因的鉴定
基本信息
- 批准号:8136114
- 负责人:
- 金额:$ 24.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdverse effectsAlzheimer&aposs DiseaseAmyloid beta-Protein PrecursorAngiotensin IIAntibodiesBiological AssayC-terminalCandidate Disease GeneCell CountCell physiologyCellsChronic Kidney FailureCleaved cellComplementary DNACoupledDTR geneDevelopmentDiseaseEGF geneEnhancersEpithelial CellsEpitopesEvaluationFluorescenceFluorochromeGenesGoalsGrantHeart DiseasesHeart failureHumanInfectionInflammationInjuryInstructionJurkat CellsKidneyKidney DiseasesKnockout MiceLacZ GenesLengthLibrariesLifeLigandsLungMalignant NeoplasmsMeasuresMetalloproteasesModelingMusPhasePhorbol EstersPhosphoric Monoester HydrolasesPhosphotransferasesPhysiologicalPolybreneProgress ReportsProtein IsoformsPuromycinRegulationResistanceSignal Transduction PathwayStaining methodStainsTransforming Growth Factor alphaTubular formationVirus Diseasesatypical protein kinase CbasecDNA Libraryhigh throughput screeninginhibitor/antagonistkillingsknock-downnoveloverexpressionpro-EGFrepairedresponsesmall hairpin RNA
项目摘要
Ectodomain (ECD) cleavage by metalloproteinases is involved in many diseases including kidney and
cardiac disease, Alzheimer's disease, cancer and inflammation. EGF pro-ligands mature by
metalloproteinase-cleavage of the ECD that represents the active ligand. They are important in a broad
range of physiological and disease states. In the kidney, as examples, the EGF ligand TGFalpha is cleaved
in response to Angiotensin II (Angll). TGFalpha knock-out mice or mice treated with a metalloprotease
inhibitor are protected against Angll-induced chronic kidney disease. HB-EGF, another EGF ligand, is
involved in tubular branching in the developing kidney and in tubular repair after kidney injury.
Metalloproteinase-directed therapies in humans are limited by side effects, or non-existent. The signal
transduction pathways regulating ECD cleavage are essentially unknown. The goal of our study is to identify
novel genes that regulate ECD cleavage using a lentiviral shRNA gene knock-down approach. We have
developed a high-throughput assay that detects cleavage of EGF-ligands in a FACS-based assay using
cells stably expressing a ligand with an ECD epitope tag and a C-terminal GFP-fusion. The ECD can be
tracked by staining with a fluorochrome-coupled antibody ("red"). In the uncleaved state any given cell has
a 1:1 ratio of outside (ECD, "red") to inside (GFP, "green") fluorescence, as measured by FACS on life
single cells. Stimulation of EGF ligand cleavage decreases, while inhibition increases this ratio. During the
K99 phase of this grant we began examining the effect of knock-down of human kinases and phosphatases
on EGF ligand cleavage. Here we present up-to-date results on the initial screen that identified several
inhibitors and activators of phorbol ester-induced TGFalpha cleavage in Jurkat cells. Knock-down of
PKCzeta, an atypical protein kinase C isoform not activated by phorbol ester is identified as an important
inhibitor of cleavage in Jurkat cells and also in mouse lung epithelial cells and partipates in differential
regulation of ECD cleavage of three different EGF ligands examined. We are outlining our plans for
completion of the high-throughput screen and for further evaluation of candidate genes, including PKCzeta.
金属蛋白酶的胞外结构域(ECD)裂解涉及许多疾病,包括肾脏和
心脏病、阿尔茨海默病、癌症和炎症。EGF的成熟
代表活性配体的ECD的金属蛋白酶裂解。它们在广泛的
生理和疾病状态的范围。例如,在肾脏中,EGF配体TGF α被切割,
血管紧张素II(AngII)。TGF α敲除小鼠或用金属蛋白酶处理的小鼠
抑制剂被保护免于AngII诱导慢性肾病。HB-EGF是EGF的另一种配体,
参与发育中的肾的肾小管分支和肾损伤后的肾小管修复。
金属蛋白酶定向疗法在人类中受到副作用的限制,或不存在。信号
调节ECD裂解的转导途径基本上是未知的。我们研究的目的是
使用慢病毒shRNA基因敲低方法调节ECD切割的新基因。我们有
开发了一种高通量测定法,该测定法在基于FACS的测定法中检测EGF配体的裂解,
稳定表达具有ECD表位标签和C-末端GFP融合体的配体的细胞。ECD可以是
通过用荧光染料偶联抗体(“红色”)染色来追踪。在未分裂状态下,任何给定的细胞都具有
外部(ECD,“红色”)与内部(GFP,“绿色”)荧光的比例为1:1,如通过FACS对寿命所测量的
单细胞刺激EGF配体裂解减少,而抑制增加这一比例。期间
在K99阶段,我们开始研究敲低人类激酶和磷酸酶的效果
表皮生长因子配体裂解。在这里,我们在初始屏幕上展示了最新的结果,其中识别了几个
在Jurkat细胞中佛波酯诱导的TGF α裂解的抑制剂和激活剂。敲低
PKCzeta是一种不被佛波酯激活的非典型蛋白激酶C亚型,被鉴定为重要的
在Jurkat细胞和小鼠肺上皮细胞中的切割抑制剂,以及在分化
检测三种不同EGF配体的ECD切割的调节。我们正在计划
完成高通量筛选和进一步评估候选基因,包括PKCzeta。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andreas Herrlich其他文献
Andreas Herrlich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andreas Herrlich', 18)}}的其他基金
Role of ADAM17 substrates in Progressive Kidney Disease
ADAM17 底物在进行性肾病中的作用
- 批准号:
9355173 - 财政年份:2016
- 资助金额:
$ 24.65万 - 项目类别:
Identification of novel genes regulating metalloproteinase activity
调控金属蛋白酶活性的新基因的鉴定
- 批准号:
8327862 - 财政年份:2010
- 资助金额:
$ 24.65万 - 项目类别:
Identification of novel genes regulating metalloproteinase activity
调控金属蛋白酶活性的新基因的鉴定
- 批准号:
8090638 - 财政年份:2010
- 资助金额:
$ 24.65万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 24.65万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 24.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 24.65万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 24.65万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 24.65万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 24.65万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 24.65万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 24.65万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 24.65万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 24.65万 - 项目类别:
Studentship














{{item.name}}会员




